Keyphrases
COVID-19
100%
Virus
61%
Influenza Virus
58%
Coronavirus
39%
Spike Protein
38%
Sialoglycans
33%
SARS-CoV-2 Infection
28%
Neuraminidase
25%
Nanoparticles
24%
Receptor-ligand Interaction
23%
Domestic Cat
23%
Antibody Response
22%
Porcine Epidemic Diarrhea Virus
21%
Elephant Endotheliotropic Herpesvirus
21%
Netherlands
21%
Hemagglutinin
19%
Sarbecoviruses
18%
Virion
18%
Receptor Binding
18%
Macrocyclic Peptides
17%
Antibody Level
17%
Receptor-binding Domain
16%
Encephalomyocarditis Virus
16%
Picornavirus
15%
Broad-spectrum Antivirals
15%
Stray Cats
15%
Zoonotic
15%
Peptide Inhibitor
14%
Virus Challenge
14%
Antibody Protection
14%
Vulnerability
14%
Stimulator of Interferon Genes (STING)
14%
Mucin 1 (MUC1)
14%
Respiratory Surface
14%
Sialic Acid Receptors
14%
Expression System
14%
Paramyxovirus
14%
Porcine deltacoronavirus (PDCoV)
14%
Nucleocapsid Protein
14%
Integrated Stress Response
14%
RNA-binding Domain
14%
Monoclonal Antibody
13%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
12%
Elephant
12%
Motility
12%
Antiviral Response
12%
Virus-specific
12%
Sialic Acid
11%
Feline Coronavirus (FCoV)
11%
Enterovirus
11%
Epithelial Cells
11%
Coxsackievirus B3 (CVB3)
11%
Adaptation
10%
Virus Infection
10%
Macrocyclization
10%
Cyclization
10%
SARS-CoV-2 Variants
10%
Thermothelomyces Heterothallica
10%
HCoV-OC43
10%
M Protein
10%
Hemagglutinin-neuraminidase
10%
Rhinovirus
10%
Neutralizing Antibodies
10%
Advisory Board
9%
Cat Diseases
9%
RNA Virus
9%
Asian Elephant
9%
Hemorrhagic Disease
9%
Piglets
9%
Specific Antibodies
9%
Double-stranded RNA
9%
Immune Evasion
9%
Receptor Binding Specificity
9%
Interdomain Crosstalk
9%
Extracellular Domain
9%
Omicron Sub-lineages
9%
Serosurvey
9%
Llama
9%
Neutralization Activity
9%
SARS-CoV-2 Variants of Concern
9%
Pseudovirus
9%
Single-domain Antibody
9%
Immune Response
9%
Antiviral Activity
9%
Confidence Interval
9%
Viral Infection
9%
Viral Shedding
9%
Low Affinity
9%
Amino Acids
8%
Cysteine
8%
Antiviral Agents
8%
Heavy-chain Antibody
8%
Future Pandemics
8%
Virus Entry
8%
Nanobody
8%
Response Activation
8%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
8%
Hamster
8%
Post Inoculation
8%
Immunogenicity
8%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
98%
Virus
86%
Spike
60%
Influenzavirus A
42%
Coronavirinae
42%
Receptor Binding
32%
Virion
29%
Hemagglutinin
26%
Zoonotic
25%
Antibody Response
22%
Domestic Cat
22%
Infectious Agent
21%
Picornaviridae
21%
Herpesviridae
21%
Viral Replication
21%
Glycoprotein
19%
Dynamics
18%
Encephalomyocarditis Virus
18%
Porcine Epidemic Diarrhea Virus
18%
Viral Disease
17%
Interferon Type I
17%
Middle East Respiratory Syndrome Coronavirus
16%
COVID-19
16%
Neutralizing Antibody
16%
Lineages
15%
Immune Response
15%
Mucin
14%
RNA Virus
14%
Paramyxoviridae
14%
Immunogenicity
14%
Influenza A Virus (H3N2)
14%
Mosaicism
14%
Influenza
14%
Single-Domain Antibody
14%
Virus Nucleocapsid
14%
RNA Recognition Motif
14%
Enterovirus D68
14%
Epitope
13%
MUC1
11%
Piglet
11%
Coronavirus
11%
Gene Expression System
10%
Hemagglutinin-Neuraminidase
10%
Neutralization
10%
Coxsackievirus B3
10%
Cryo-Electron Microscopy
10%
Aves
10%
Viral Entry
9%
Microsomal Aminopeptidase
9%
Protein Targeting
9%
Viral Shedding
9%
Llama
8%
Adoptive Immunity
8%
Cladistics
8%
Host Cell
8%
Cell Culture
8%
Glycan
8%
SARS Coronavirus
8%
Stray Cat
7%
Monoclonal Antibody
7%
Point Mutation
7%
Nucleotide Metabolism
7%
Filamentous Fungus
7%
Human Monoclonal Antibody
7%
Agonist
7%
Endoplasmic reticulum
7%
Trans Golgi Network
7%
Kinome
7%
Human Respiratory Syncytial Virus
7%
Betacoronavirus
7%
Coronaviridae
7%
Heavy Chain
7%
Enterovirus D
7%
Avian Infectious Bronchitis Virus
7%
Morbillivirus
7%
Alphavirus
7%
CRISPR/Cas9
7%
Polymerase Chain Reaction
7%
Cell Activation
7%
Natural Killer Cell
7%
Influenza A Virus (H1N1)
7%
Titer
7%
Influenza Vaccine
7%
Antibody Titer
7%
Yeast Two-Hybrid Screening
7%
Myosin
7%
Host Factor
7%
Hemagglutinin Esterase
7%
Bovine Coronavirus
7%
Lectin
7%
Enterovirus
6%
Cell Surface
6%
Omicron Coronavirus Variant
5%
Virus Genome
5%
Viral Load
5%
Conformational Transition
5%
MUC16
5%
Virus Attachment
5%
Respiratory Syncytial Virus Infection
5%